Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
ST-Bio-Life LLC
2022
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/13671 |
| Aporte de: |
| id |
I33-R139123456789-13671 |
|---|---|
| record_format |
dspace |
| institution |
Universidad Católica Argentina |
| institution_str |
I-33 |
| repository_str |
R-139 |
| collection |
Repositorio Institucional de la Universidad Católica Argentina (UCA) |
| language |
Inglés |
| topic |
MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS |
| spellingShingle |
MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| topic_facet |
MELATONINA SARS-CoV-19 VARIANTE DELTA COVID-19 VARIANTES FUTURAS |
| description |
Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective
against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus. |
| format |
Artículo |
| author |
Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan |
| author_facet |
Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan |
| author_sort |
Reiter, Russel J. |
| title |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_short |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_full |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_fullStr |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_full_unstemmed |
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 |
| title_sort |
rationale for the continued use of melatonin to combat the delta variant of sars-cov-2 |
| publisher |
ST-Bio-Life LLC |
| publishDate |
2022 |
| url |
https://repositorio.uca.edu.ar/handle/123456789/13671 |
| work_keys_str_mv |
AT reiterrusselj rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT cardinalidanielpedro rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT neelrichardl rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT dominguezrodriguezalberto rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT browngregorym rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 AT tesarikjan rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2 |
| bdutipo_str |
Repositorios |
| _version_ |
1764820526390312960 |